Summit Therapeutics PLC's stock price rose significantly in pre-market trading, with an increase of 4.1%.

05:27 PM EDT, 10/08/2026 (MT Newswires) -- Bombardier (BBD-B.TO) after trade Thursday said it is opening a new Line Maintenance Station in Sydney, Australia, expanding its network in the Asia-Pacific region. The aircraft manufacturer said the move adds to its existing Australian facilities in Perth and Melbourne. The Sydney location will provide emergency aircraft-on-ground support, unscheduled maintenance and select scheduled inspections. It will also offer mobile response capabilities, with technicians certified to service Bombardier's Learjet, Challenger and Global aircraft, the company said. "The site's new Component Repair and Overhaul workshop will further strengthen Bombardier's capabilities in APAC," it added.

Ser Educacional disclosed executive management (Diretoria) spot sales of 7,100 ON shares during the month. Total proceeds were R$ 97,593; average sale price R$ 13.7455 per share. No qualifying spot transactions were reported for the majority shareholder (Controlador), board, audit committee, or advisory board. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ser Educacional SA published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.

05:05 PM EDT, 10/08/2026 (MT Newswires) -- Quantum-Si (QSI) said Thursday it demonstrated detection of 19 amino acids in its Proteus protein sequencing program and is working to deploy the capability into a developmental sequencing kit for routine use on integrated Proteus instruments. The progress follows interim Proteus data presented at the 2026 World HUPO Congress, where a developmental kit detected 18 amino acids. Quantum-Si remains confident in demonstrating detection of all 20 amino acids by year-end and continues to target commercial launch of Proteus in Q2 of 2027, according to the company.